Status:
COMPLETED
Sevoflurane in Electroconvulsive Therapy
Lead Sponsor:
Inonu University
Conditions:
ECT
Anesthesia
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles
Detailed Description
Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times were recorded.
Eligibility Criteria
Inclusion
- Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia
Exclusion
- Pregnancy
- Cerebrovascular disease
- Epilepsy
- Unstable cardiovascular disease
- Chronic obstructive pulmonary disease; and
- Renal or hepatic failure
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01905904
Start Date
March 1 2013
End Date
June 1 2013
Last Update
May 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inonu Unıversity School of Medicine
Malatya, Turkey (Türkiye), 44100